Skip to main content
. 2016 Jan 5;16:4. doi: 10.1186/s12885-015-2019-x

Table 5.

Correlates of lifestyle behaviors

Lifestyle behavior
Number of alcohol consumption Number of vegetable consumption Number of fruit consumption Amount of physical activity Nonsmoking
(N = 223) (N = 225) (N = 228) (N = 225) (N = 141)a
Variable B (95 % CI) p B (95 % CI) p B (95 % CI) p B (95 % CI) p ExpB (95 % CI) P c
Age . 037 (-.15; .23) .698 −1.307 (-2.70; .09) .067 .007 (-.01; .02) .367 −13.723 (-25.94; -1.51) .028* .936 (.86; 1.02) .127
Female gender −5.805 (-11.13; -4.77) .033* 7.579 (-32.98; 48.14) .713 .211 (-.20; .63) .315 −11.993 (-361.07; 337.08) .946 .394 (.04; 4.45) .399
Marital status
 Without partner ref ref ref ref
 With partner −4.986 (-10.75; .73) .089 24.032 (-17.65; 65.72) .257 .174 (-.25; .60) .421 −122.543 (-478.92; 233.83) .498
Education
 Low ref ref ref ref ref .198
 Medium −1.165 (-5.60; 3.72) .605 14.521 (-17.78; 64.82) .376 -.019 (-.35; .31) .907 −176.621 (-451.64; 98.40) .207 2.664 (.52; 13.75) .242
 High −2.370 (-6.64; 1.90) .274 18.004 (-1.71; 49.72) .264 .075 (-.25; .40) .644 −215.435 (-474.80; 43.93) .103 5.451 (.72; 41.44) .101
Income
 Above average ref ref ref ref
 Average −2.646 (-6.42; 1.13) .168 −19.041 (-47.66; 9.58) .191 -.118 (-.41; .17) .423 71.279 (-169.63; 312.19) .560
 Below average −4.183 (-9.78; 1.41) .142 −6.040 (-47.44; 35.36) .774 .022 (-.40; .45) .917 −77.931 (-431.78; 275.19) .654
Cancer type
 Other ref ref ref ref ref .096
 Breast −1.244 (-7.97; 5.48) .716 −1.055 (-51.79; 49.68) .967 -.046 (-.56; .47) .862 137.614 (-291.14; 566.37) .527 .489 (.02; 12.11) .662
 Colon −1.859 (-8.18; 4.46) .562 5.333 (-42.80; 53.47) .827 .002 (-.49; .49) .995 15.656 (-390.56; 421.88) .939 .045 (.00; 1.04) .053
Treatment
 Allb ref ref ref ref ref .554
 Surgery alone 1.914 (-4.18; 8.01) .536 −6.261 (-51.72; 39.20) .786 -.077 (-.54; .39) .745 −67.186 (-443.93; 309.56) .725 .483 (.04; 5.73) .565
 Surgery, chemo .991 (-3.40; 5.38) .657 -.259 (-33.72; 33.20) .988 −0.52 (-.39; .29) .764 56.566 (-223.74; 3236.87) .691 3.975 (.38; 41.21) .247
 Surgery, radiation .228 (-4.88; 5.34) .930 −15.436 (-52.36; 21.49) .411 .031 (-.35; .21) .872 −43.457 (-358.83; 271.92) .786 .471 (.06; 3.68) .473
 Other -.041 (-7.96; 7.88) .992 -.947 (-60.33; 58.44) .975 -.144 (-.74; .45) .633 −70.914 (-559.88; 418.05) .775 1.275 (.04; 43.16) .893
Aftercare
 No ref ref ref ref
 Yes 1.914 (-5.00; 2.39) .487 −15.766 (-43.27; 11.74) .260 -.070 (-.35; .21) .622 −60.426 (-291.29; 170.44) .606
Time after treatment .991 (-.236; .026) .117 1.053 (.09; 2.02) .032* .003 (-.01; .01) .500 .787 (-7.26; 8.83) .874
BMI -.257 (-.654; .14) .203 1.654 (-1.32; 4.63) .274 -.013 (-.04; .02) .376 −7.844 (-33.21; 17.53) .453
Glob. Health/ QoL .044 (-.10; .12) .543 -.412 (-1.48; .67) .451 -.002 (-.01; .01) .732 .246 (-8.74; 9.23) .957 .926 (.86; 1.00) .052
Physical funct. .008 (-.17; .18) .929 -.676 (-1.99; .46) .313 -.007 (-.02; .01) .314 5.129 (-6.24; 16.50) .374
Role funct. –.076 (-.20; .05) .199 .521 (-.38; 1.42) .254 .006 (-.00; .02) .164 4.379 (–3.05; 11.81) .246
Emotional funct. –.078 (–.20: .05) .226 .263 (–.71; 1.24) .593 .003 (–.01; .01) .554 7.327 (–.94; 15.59) .082
Cognitive funct. –.013 (–.12; .09) .796 –.079 (–.86; .70) .840 –.002 (–.01; .01) .600 .192 (–7.84; 6.51) .953 .957 (.92; 1.00) .055
Social funct. .070 (–.05; .19) .234 –.466 (–1.32; .39) .285 –.003 (–.01; .01) .488 –.661 (–7.84; 6.51) .856 1.046 (1.00; 1.09) .038*
Body Image .016 (–.07; .10) .703 .010 (–.65; .66) .977 .000 (–.01; .01) .935 1.977 (–3.43; 7.38) .471
Fatigue .046 (–.07; .16) .436 .269 (–.63; 1.16) .554 .001 (–.01; .01) .744 7.732 (.30; 12.15) .041*
Nausea,vomiting –.043 (–.23; .15) .651 –.071 (–1.56; 1.42) .925 .000 (–.02; .01) .957 −2.743 (–14.78; 9.29) .654 .945 (.89; 1.01) .081
Pain –.034 (–.13; .06) .472 .169 (–.56; .90) .650 .001 (–.01; .01) .784 6.229 (.31; 15.16) .039*
Dyspnea –.025 (–.11; .06) .553 –.428 (–1.07;.21) .188 –.004 (–.01; .00) .277 .010 (–5.19; 5.21) .997
Insomnia –.062 (–.13; .00) .058 .214 (–.27; .70) .382 .000 (–.00; .01) .866 .850 (–3.13; 4.83) .674 .977 (.95; 1.01) .108
Appetite loss .033 (–.08; .15) .576 –.168 (–1.05; .72) .708 .001 (–.01; .01) .805 4.505 (–2.91; 11.91) .223
Constipation –.036 (–.12; .03) .452 –.374 (–1.10; .35) .310 –.005 (–.01; .00) .186 −5.298 (–11.12; .53) .074
Diarrhea .030 (–.13; .06) .503 .111 (–.59; .81) .754 .003 (–.01; .01) .383 .151 (–5.57; 5.87) .959
Financial probl. .001 (–.09; .09) .987 –.339 (–.99; .31) .302 –.001 (–.01; .01) .827 .024 (–5.44; 5.49) .993 .977 (.95; 1.01) .157
Anxiety –.080 (–.78; .62) .820 –.084 (–5.43; 5.26) .975 –.008 (–.06; .05) .760 41.203 (–3.24; 85.65) .069 .682 (.50; .93) .015*
Depression .170 (–.60; .94) .662 –.204 (–6.03; 5.62) .945 –.027 (–.09; .03) .365 −33.248 (–80.72; 14.22) .169 1.187 (.89; 1,58) .236
Pos. adjustment –.057 (–.32; .20) .667 2.297 (.34; 4.26) .022* .013 (–.02; .03) .198 12.872 (–3.001; 28.75) .111
Neg. adjustment –.149 (–.48; .18) .373 −1.992 (–4.40; .42) .105 .005 (–.02; .03) .714 6.782 (–13.48; 27.04) .510
Illness perception –.034 (–.24; .17) .738 .782 (–.71; 2.28) .303 .010 (–.01; .03) .189 −4.296 (–16.86; 8.27) .501
PPO 1.324 (–1.05; 3.70) .273 −4.790 (–22.60; 13.02) .596 –.001 (–.18; .18) .991 −78.106 (–225.46; 69.24) .297
NPO .457 (–1.75; 2.66) .684 2.240 (–14.26; 18.74) .789 –.078 (–.25; .09) .360 −82.287 (–222.29; 57.73) .248
Attitude 1.522 (–.32; 3.36) .105 17.076 (–1.98; 36.13) .079 –.016 (–.21; .18) .872 192.876 (–19.74; 405.49) .075 5.707 (1.83; 17.7) .003**
Social support –.004 (–.01; .00) .290 –.012 (–.19; .17) .894 0.00 (–.00; .00) .710 –.111 (–1.62; 1.40) .884
Self–efficacy −1.532 (–2.81; –.25) .019* 11.342 (–3.70; 26.36) .138 .070 (–.09; .23) .378 181.637 (54.71; 308.56) .005* 2.583 (1.42; 4.69) .002**
Intention .479 (–1.02; 1.98) .530 36.980 (23.16; 50.81) .000** .597 (.48; .72) .000** 137.551 (–23.15; 298.25) .093 .583 (.58; 1.56) .852
Constant B (SE) 35.146 (20.40) −105.53 (151.51) −1.63 (1.54) −2456.07 (1356.25) 2.96 (5.07)
R2 .297 .415 .514 .312
Sig. F Change .530 .000 .000 .093
Cox & Snell R2 .518
Nagelkerke R2 .725
Model X 2 102.87
p .000

Note: From Sequential Multiple Regression (continuous outcomes) and Sequential Logistic Regression (smoking) entry step 4 is displayed. Forced entry (enter) method was used; Abbreviations: ExpB: odds ratio; ref: reference group; BMI: Body Mass Index; EORTC: European Organisation for Research and Treatment of Cancer; QoL: Quality of Life; HADS: Hospital Anxiety and Depression Scale; neg./pos. adjustment from MAC: Mental Adjustment to Cancer Scale; IPQ: Illness Perception Questionnaire; SPSIR–R:S Short Social Problem Solving Inventory–Revised; Chemo: chemotherapy; PPO: positive problem orientation; NPO: negative problem orientation

aDependent variable encoding: if participant is former smoker 1; if participant is current smoker 0; never–smokers were excluded

ball = surgery + chemotherapy + radiation

c p–value of Wald test is presented

*p < 0.05; **p < 0.01